minoxidil has been researched along with Breast Cancer in 8 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Topical minoxidil has been shown to be effective for androgenetic alopecia and alopecia areata." | 9.08 | A randomized trial of minoxidil in chemotherapy-induced alopecia. ( Bandstra, BA; Compton, LD; Duvic, M; Farmer, KL; Hortobagyi, GN; Hymes, SR; Lemak, NA; Trancik, RJ; Valero, V, 1996) |
| "To analyze the clinical and histological features of permanent alopecia following a sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel regimen for adjuvant breast cancer treatment." | 7.78 | Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients. ( Bessis, D; Dereure, O; Frouin, E; Guillot, B; Jacot, W; Kluger, N; Poujol, S; Rigau, V; Romieu, G, 2012) |
| " Topical minoxidil has been shown to be effective for androgenetic alopecia and alopecia areata." | 5.08 | A randomized trial of minoxidil in chemotherapy-induced alopecia. ( Bandstra, BA; Compton, LD; Duvic, M; Farmer, KL; Hortobagyi, GN; Hymes, SR; Lemak, NA; Trancik, RJ; Valero, V, 1996) |
| "The clinical features, alopecia-related quality of life (QoL), and response to minoxidil of EIA in patients with breast cancer were assessed." | 3.88 | Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer. ( Chan, D; Dusza, S; Fornier, M; Freites-Martinez, A; Gajria, D; Goldfarb, S; Lacouture, ME; Modi, S; Shapiro, J, 2018) |
| "To analyze the clinical and histological features of permanent alopecia following a sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel regimen for adjuvant breast cancer treatment." | 3.78 | Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients. ( Bessis, D; Dereure, O; Frouin, E; Guillot, B; Jacot, W; Kluger, N; Poujol, S; Rigau, V; Romieu, G, 2012) |
| "Alopecia is a common cutaneous adverse event reported with CK4/6i therapy." | 1.91 | Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients. ( Cathcart-Rake, E; Cherian, M; Dulmage, B; Gatti-Mays, M; Loprinzi, CL; Lustberg, M; Minta, A; Park, C; Ramaswamy, B; Rose, L; Ruddy, KJ; Sardesai, S; Stover, D; Sudheendra, P; Trovato, S; Wesolowski, R; Williams, N, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, J | 2 |
| Lee, JW | 2 |
| Kwon, O | 2 |
| Minta, A | 1 |
| Rose, L | 1 |
| Park, C | 1 |
| Ramaswamy, B | 1 |
| Stover, D | 1 |
| Gatti-Mays, M | 1 |
| Cherian, M | 1 |
| Williams, N | 1 |
| Sudheendra, P | 1 |
| Wesolowski, R | 1 |
| Sardesai, S | 1 |
| Lustberg, M | 1 |
| Loprinzi, CL | 1 |
| Ruddy, KJ | 1 |
| Cathcart-Rake, E | 1 |
| Trovato, S | 1 |
| Dulmage, B | 1 |
| Freites-Martinez, A | 1 |
| Shapiro, J | 1 |
| Chan, D | 1 |
| Fornier, M | 1 |
| Modi, S | 1 |
| Gajria, D | 1 |
| Dusza, S | 1 |
| Goldfarb, S | 1 |
| Lacouture, ME | 1 |
| Trüeb, RM | 1 |
| Kluger, N | 1 |
| Jacot, W | 1 |
| Frouin, E | 1 |
| Rigau, V | 1 |
| Poujol, S | 1 |
| Dereure, O | 1 |
| Guillot, B | 1 |
| Romieu, G | 1 |
| Bessis, D | 1 |
| Molinatti, GM | 1 |
| Biffignandi, P | 1 |
| Massucchetti, C | 1 |
| Duvic, M | 2 |
| Lemak, NA | 1 |
| Valero, V | 1 |
| Hymes, SR | 1 |
| Farmer, KL | 1 |
| Hortobagyi, GN | 1 |
| Trancik, RJ | 1 |
| Bandstra, BA | 1 |
| Compton, LD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Controlled Trial to Evaluate Effectiveness of Cooling Cap to Prevent Permanent Chemotherapy-induced Alopecia Among Breast Cancer Patients[NCT04678544] | 170 participants (Actual) | Interventional | 2020-12-23 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for minoxidil and Breast Cancer
| Article | Year |
|---|---|
[Intracellular and extracellular proteins binding androgenic hormones. Biochemical properties and clinical significance].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Androgen-Binding Protein; Androgen-Insensitivity Syndrom | 1983 |
1 trial available for minoxidil and Breast Cancer
| Article | Year |
|---|---|
A randomized trial of minoxidil in chemotherapy-induced alopecia.
Topics: Administration, Cutaneous; Adult; Alopecia; Antibiotics, Antineoplastic; Antimetabolites, Antineopla | 1996 |
6 other studies available for minoxidil and Breast Cancer
| Article | Year |
|---|---|
Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: A retrospective cohort study.
Topics: Administration, Topical; Alopecia; Breast Neoplasms; Female; Humans; Minoxidil; Patients; Retrospect | 2023 |
Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: A retrospective cohort study.
Topics: Administration, Topical; Alopecia; Breast Neoplasms; Female; Humans; Minoxidil; Patients; Retrospect | 2023 |
Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: A retrospective cohort study.
Topics: Administration, Topical; Alopecia; Breast Neoplasms; Female; Humans; Minoxidil; Patients; Retrospect | 2023 |
Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: A retrospective cohort study.
Topics: Administration, Topical; Alopecia; Breast Neoplasms; Female; Humans; Minoxidil; Patients; Retrospect | 2023 |
Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients.
Topics: Administration, Cutaneous; Alopecia; Breast Neoplasms; Cyclin-Dependent Kinase 4; Female; Humans; Mi | 2023 |
Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bre | 2018 |
Minoxidil for Endocrine Therapy-Induced Alopecia in Women With Breast Cancer-Saint Agatha's Blessing?
Topics: Alopecia; Breast; Breast Neoplasms; Female; Humans; Minoxidil | 2018 |
Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast | 2012 |
Chemotherapy-induced alopecia.
Topics: Administration, Topical; Alopecia; Animals; Antineoplastic Agents; Antineoplastic Combined Chemother | 1993 |